BECAUSE ANSWERS TO CANCERS COME FROM CLINICAL TRIALS Trademark

Trademark Overview

On Friday, June 30, 2006, a trademark application was filed for BECAUSE ANSWERS TO CANCERS COME FROM CLINICAL TRIALS with the United States Patent and Trademark Office. The USPTO has given the BECAUSE ANSWERS TO CANCERS COME FROM CLINICAL TRIALS trademark a serial number of 78920982. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, February 14, 2018. This trademark is owned by The Hope Foundation. The BECAUSE ANSWERS TO CANCERS COME FROM CLINICAL TRIALS trademark is filed in the Insurance & Financial Services category with the following description:

Charitable fundraising services for cancer research
because answers to cancers come from clinical trials

General Information

Serial Number78920982
Word MarkBECAUSE ANSWERS TO CANCERS COME FROM CLINICAL TRIALS
Filing DateFriday, June 30, 2006
Status800 - REGISTERED AND RENEWED
Status DateWednesday, February 14, 2018
Registration Number3379627
Registration DateTuesday, February 5, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 20, 2007

Trademark Statements

Goods and ServicesCharitable fundraising services for cancer research

Classification Information

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, July 7, 2006
Primary Code036
First Use Anywhere DateWednesday, May 31, 2006
First Use In Commerce DateWednesday, May 31, 2006

Trademark Owner History

Party NameThe Hope Foundation
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAnn Arbor, MI 48106
Party NameThe Hope Foundation
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAnn Arbor, MI 48106
Party NameThe Hope Foundation
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAnn Arbor, MI 48106

Trademark Events

Event DateEvent Description
Wednesday, February 14, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, February 14, 2018REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, February 14, 2018REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, February 14, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, January 25, 2018TEAS SECTION 8 & 9 RECEIVED
Monday, July 24, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, February 5, 2017COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, January 30, 2014NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, January 30, 2014REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, January 20, 2014REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Thursday, January 30, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, January 20, 2014TEAS SECTION 8 & 15 RECEIVED
Thursday, February 21, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 29, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 29, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 5, 2008REGISTERED-PRINCIPAL REGISTER
Friday, December 28, 2007LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, December 27, 2007ASSIGNED TO LIE
Wednesday, December 19, 2007ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, December 6, 2007STATEMENT OF USE PROCESSING COMPLETE
Thursday, December 6, 2007EXTENSION 1 GRANTED
Tuesday, November 13, 2007USE AMENDMENT FILED
Tuesday, November 13, 2007EXTENSION 1 FILED
Tuesday, November 13, 2007TEAS EXTENSION RECEIVED
Tuesday, November 13, 2007TEAS STATEMENT OF USE RECEIVED
Tuesday, May 15, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 20, 2007PUBLISHED FOR OPPOSITION
Wednesday, January 31, 2007NOTICE OF PUBLICATION
Monday, January 8, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, January 6, 2007ASSIGNED TO LIE
Wednesday, December 13, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 1, 2006ASSIGNED TO EXAMINER
Friday, July 7, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

clinical trials from come answers cancers because research cancer services fundraising charitable